Restricted Hazardous Substances (RoHS)

EU Directives restrict the use of hazardous substances in electrical and electronic equipment

European Union (EU) Directives have restricted the use of certain hazardous substances in electrical and electronic equipment for more than a decade. Originally issued in 2002, EU Directive 2002/95/EC (also known as the RoHS Directive) restricted the use of the six chemicals lead, cadmium, mercury, and hexavalent chromium, as well as flame retardants polybrominated biphenyls (PBBs) and polybrominated dipheny ethers (PBDEs). Under the RoHS Directive, manufacturers are required to replace these chemicals in their products with less hazardous alternatives.

In 2014, the substance restrictions of the RoHS Directive will be applicable to medical devices. Under EU Directive 2011/65/EU (also known as RoHS II), medical devices will be subject to restrictions regarding the use of hazardous substances as of 22 July 2014, and in vitro diagnostic medical devices will be required to comply with hazardous substances restrictions as of 22 July 2016. For now, active implantable medical devices remain outside the scope of RoHS requirements, but are subject to future review by the EU Commission.

Compliance with the requirements of the EU’s RoHS II Directive requires manufacturers to adhere to the conformity assessment procedures presented in Annex II Module A of EU Commission Decision No. 768/2008/EC: “The manufacturer shall establish the technical documentation. The documentation shall make it possible to assess the product's conformity to the relevant requirements, and shall include an adequate analysis and assessment of the risk(s). The technical documentation shall specify the applicable requirements and cover, as far as relevant for the assessment, the design, manufacture and operation of the product”.

Medical device manufacturers are advised to thoroughly review the conformity assessment procedures applicable to their device to avoid delays in the product review and approval process.

Compliance with the essential requirements of the EU’s directives and regulations applicable to active, non-active and in-vitro medical devices provides manufacturers with access to a marketplace consisting of 500 million consumers. In addition, medical devices bearing the CE marking may achieve faster regulatory review and approval in other global markets. TÜV SÜD Product Service is the world’s largest EU Notified Body for medical devices. In addition, TÜV SÜD’s extensive international network makes it an effective single source for manufacturers seeking global market access for their products.

Voluntary RoHS II compliance assessment for medical devices - The basis for this assessment is RoHS II, the technical documentation according to Annex II Module A of Decision 768/2008/EC, EN 50581, IEC 62596 and IEC 62474. This assessment is product related and not system related and can be done off-site at TÜV SÜD laboratories or on-site at your manufacturing facility.

TÜV SÜD RoHS certification mark - The TÜV SÜD RoHS mark attests that the product has been tested, inspected and certified in accordance with the RoHS Directive.

Product safety testing and certification - TÜV SÜD Product Service is an EU Notified Body for medical devices, and is recognised by other regulatory agencies throughout the world for its extensive experience with a broad range of medical devices.

In 2014, the substance restrictions of the RoHS Directive will be applicable to medical devices. Under EU Directive 2011/65/EU (also known as RoHS II), medical devices will be subject to restrictions regarding the use of hazardous substances as of 22 July 2014, and in vitro diagnostic medical devices will be required to comply with hazardous substances restrictions as of 22 July 2016. For now, active implantable medical devices remain outside the scope of RoHS requirements, but are subject to future review by the EU Commission.

Compliance with the requirements of the EU’s RoHS II Directive requires manufacturers to adhere to the conformity assessment procedures presented in Annex II Module A of EU Commission Decision No. 768/2008/EC: “The manufacturer shall establish the technical documentation. The documentation shall make it possible to assess the product's conformity to the relevant requirements, and shall include an adequate analysis and assessment of the risk(s). The technical documentation shall specify the applicable requirements and cover, as far as relevant for the assessment, the design, manufacture and operation of the product”.

Medical device manufacturers are advised to thoroughly review the conformity assessment procedures applicable to their device to avoid delays in the product review and approval process.

Compliance with the essential requirements of the EU’s directives and regulations applicable to active, non-active and in-vitro medical devices provides manufacturers with access to a marketplace consisting of 500 million consumers. In addition, medical devices bearing the CE marking may achieve faster regulatory review and approval in other global markets. TÜV SÜD Product Service is the world’s largest EU Notified Body for medical devices. In addition, TÜV SÜD’s extensive international network makes it an effective single source for manufacturers seeking global market access for their products.

Voluntary RoHS II compliance assessment for medical devices - The basis for this assessment is RoHS II, the technical documentation according to Annex II Module A of Decision 768/2008/EC, EN 50581, IEC 62596 and IEC 62474. This assessment is product related and not system related and can be done off-site at TÜV SÜD laboratories or on-site at your manufacturing facility.

TÜV SÜD RoHS certification mark - The TÜV SÜD RoHS mark attests that the product has been tested, inspected and certified in accordance with the RoHS Directive.

Product safety testing and certification - TÜV SÜD Product Service is an EU Notified Body for medical devices, and is recognised by other regulatory agencies throughout the world for its extensive experience with a broad range of medical devices.

Your benefits at a glance

Recognised medical device expertise - TÜV SÜD Product Service is the largest EU Notified Body in the world. With a Regulatory Foreign Affairs and Clinical Affairs Department, TÜV SÜD Product Service is recognised by regulatory authorities around the world for its extensive experience with all types of medical devices.

Quality system certification and auditing expertise - Medical device approvals routinely require the implementation of a quality management system. TÜV SÜD conducts quality management system certifications, audits and factory inspections consistent with most international regulations and standards, allowing clients to enjoy the benefits of coordinated inspections and audits, while reducing downtime and costs.

Active involvement in standards development and implementation - TÜV SÜD Product Service technical professionals are actively involved in standards development activities related to medical devices, and participate in a number of key standards committees. TÜV SÜD Product Service is also a member of Team NB, the European Association for Medical Devices of Notified Bodies, which facilitates the exchange of information on standards and regulations applicable to medical devices.

Expert partnership - TÜV SÜD Product Service has a long record of technical and regulatory expertise for medical devices, and is a trusted partner to companies ranging from global manufacturers to regional and local research and development firms.